Concepedia

Publication | Open Access

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial

41

Citations

28

References

2022

Year

Abstract

AstraZeneca and the UK Department of Health and Social Care through the UK National Institute for Health and Care Research.

References

YearCitations

Page 1